[go: up one dir, main page]

AU2003201360A1 - Methods of Reducing or Maintaining Reduced Levels of Blood Lipids Using OB Protein Compositions - Google Patents

Methods of Reducing or Maintaining Reduced Levels of Blood Lipids Using OB Protein Compositions

Info

Publication number
AU2003201360A1
AU2003201360A1 AU2003201360A AU2003201360A AU2003201360A1 AU 2003201360 A1 AU2003201360 A1 AU 2003201360A1 AU 2003201360 A AU2003201360 A AU 2003201360A AU 2003201360 A AU2003201360 A AU 2003201360A AU 2003201360 A1 AU2003201360 A1 AU 2003201360A1
Authority
AU
Australia
Prior art keywords
reducing
methods
reduced levels
protein compositions
blood lipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003201360A
Other versions
AU2003201360B2 (en
Inventor
Mary Ann Pelleymounter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU26451/00A external-priority patent/AU2645100A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to AU2003201360A priority Critical patent/AU2003201360B2/en
Publication of AU2003201360A1 publication Critical patent/AU2003201360A1/en
Application granted granted Critical
Publication of AU2003201360B2 publication Critical patent/AU2003201360B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003201360A 1995-08-17 2003-03-19 Methods of Reducing or Maintaining Reduced Levels of Blood Lipids Using OB Protein Compositions Ceased AU2003201360B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003201360A AU2003201360B2 (en) 1995-08-17 2003-03-19 Methods of Reducing or Maintaining Reduced Levels of Blood Lipids Using OB Protein Compositions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US516263 1995-08-17
AU26451/00A AU2645100A (en) 1995-08-17 2000-04-05 Methods of reducing or maintaining reduced levels of blood lipids using OB protein compositions
AU2003201360A AU2003201360B2 (en) 1995-08-17 2003-03-19 Methods of Reducing or Maintaining Reduced Levels of Blood Lipids Using OB Protein Compositions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU26451/00A Division AU2645100A (en) 1995-08-17 2000-04-05 Methods of reducing or maintaining reduced levels of blood lipids using OB protein compositions

Publications (2)

Publication Number Publication Date
AU2003201360A1 true AU2003201360A1 (en) 2003-06-12
AU2003201360B2 AU2003201360B2 (en) 2005-10-06

Family

ID=3715017

Family Applications (2)

Application Number Title Priority Date Filing Date
AU26451/00A Abandoned AU2645100A (en) 1995-08-17 2000-04-05 Methods of reducing or maintaining reduced levels of blood lipids using OB protein compositions
AU2003201360A Ceased AU2003201360B2 (en) 1995-08-17 2003-03-19 Methods of Reducing or Maintaining Reduced Levels of Blood Lipids Using OB Protein Compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU26451/00A Abandoned AU2645100A (en) 1995-08-17 2000-04-05 Methods of reducing or maintaining reduced levels of blood lipids using OB protein compositions

Country Status (1)

Country Link
AU (2) AU2645100A (en)

Similar Documents

Publication Publication Date Title
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
AU1641295A (en) Method of making soft tissue products
HUP9801370A3 (en) Stable protein:phospholipid compositions and methods for production thereof
AU696092B2 (en) Estimation of excitation parameters
AU5793396A (en) Human interferon tau compositions and methods of use
AU4597596A (en) Prevention of protein aggregation
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
AU1023797A (en) Reduction of hair growth
AU5178196A (en) Reduction of hair growth
AU4967296A (en) Water stop compositions and methods of preparing same
AUPN271295A0 (en) Method of treatment
AU3549397A (en) Over-expression of proteins
AU7073096A (en) Inhibited biological degradation of oligodeoxynucleotides
AU1436797A (en) Mitogen-activated protein kinase kinase mek6 and methods of use therefor
AU6489996A (en) Methods for increasing protein expression
AU2467395A (en) Novel ophthalmologic uses of protein c
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU7115996A (en) Uses of bone morphogenetic proteins
AU5427398A (en) Cytoperfusion of tissue specimens
AU5631096A (en) Antihistamine-wound healing compositions and methods for pre paring and using same
AU1152897A (en) Preparation method of physiologically active compound
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU7318396A (en) Methods of preserving microorganisms
AU7482696A (en) Methods for administration of il-12